Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Sinocare Yönetim

Yönetim kriter kontrolleri 4/4

Sinocare's CEO is Shao Bo Li, appointed in Aug 2002, has a tenure of 22.17 years. directly owns 25.76% of the company’s shares, worth CN¥4.32B. The average tenure of the management team and the board of directors is 16.2 years and 4.8 years respectively.

Anahtar bilgiler

Shao Bo Li

İcra Kurulu Başkanı

CN¥326.1k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	22.2yrs
CEO sahipliği	25.8%
Yönetim ortalama görev süresi	16.2yrs
Yönetim Kurulu ortalama görev süresi	4.8yrs

Son yönetim güncellemeleri

Recent updates

CEO

Shao Bo Li (59 yo)

22.2yrs

Görev süresi

CN¥326,100

Tazminat

Mr. Shao Bo Li serves as the Chairman and General Manager at Sinocare Inc. since August 07, 2002.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shao Bo Li	Chairman & GM	22.2yrs	CN¥326.10k	25.76% CN¥ 4.3b
Shi Min Wang	Deputy General Manager	16.2yrs	CN¥318.40k	0.14% CN¥ 23.3m
Jianwen Cai	Deputy General Manager	4yrs	CN¥2.27m	Veri yok
Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	no data	Veri yok	Veri yok
Chungeng Chen	Supervisor & Supply Chain Director	no data	Veri yok	Veri yok

16.2yrs

Ortalama Görev Süresi

50yo

Ortalama Yaş

Deneyimli Yönetim: 300298's management team is seasoned and experienced (16.2 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Shao Bo Li	Chairman & GM	22.2yrs	CN¥326.10k	25.76% CN¥ 4.3b
Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	7.8yrs	Veri yok	Veri yok
Chungeng Chen	Supervisor & Supply Chain Director	6.5yrs	Veri yok	Veri yok
Hong Yuan	Independent Director	4.8yrs	CN¥120.00k	Veri yok
Hongjing Che	Non-Independent Director	9.1yrs	CN¥120.00k	0.051% CN¥ 8.6m
Hui Li	Non-Independent Director	4.8yrs	CN¥120.00k	Veri yok
Xixiong Kang	Independent Director	4.8yrs	CN¥120.00k	Veri yok
Jizheng Chen	Independent Director	1.8yrs	CN¥120.00k	Veri yok
Xinyi Li	Vice Chairman	1.8yrs	CN¥565.40k	Veri yok

4.8yrs

Ortalama Görev Süresi

48yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 300298's board of directors are considered experienced (4.8 years average tenure).

Sinocare Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Approves Board Elections

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Recent updates

New minor risk - Share price stability

Sinocare Inc. to Report Q3, 2024 Results on Oct 24, 2024

Now 21% overvalued after recent price rise

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 2Q 2023)

Sinocare Inc.'s (SZSE:300298) Price Is Out Of Tune With Earnings

Calculating The Intrinsic Value Of Sinocare Inc. (SZSE:300298)

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Is Sinocare (SZSE:300298) A Risky Investment?

Sinocare's (SZSE:300298) Soft Earnings Don't Show The Whole Picture

Price target decreased by 8.0% to CN¥31.01

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc.'s (SZSE:300298) P/E Is On The Mark

Now 21% undervalued after recent price drop

Here's What To Make Of Sinocare's (SZSE:300298) Decelerating Rates Of Return

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 24%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Price target decreased by 14% to CN¥33.71

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to CN¥39.34

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to CN¥20.73

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

Price target decreased to CN¥40.66

Consensus forecasts updated

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

New 90-day high: CN¥46.30

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş